For Bin Ni, innovation is not just about discovering the next breakthrough medicine – it is also about advancing the way those medicines are tested. As a Bioanalysis Scientist in the Pharmacokinetics (PK) group within Teva’s Specialty Bioanalytics department, Bin works at the forefront of drug development. Based in the US, his daily mission is to design precise testing methods required to measure exactly how Teva’s innovative pipeline molecules behave inside the body. By combining advanced laboratory automation with humanitarian science and a collaborative approach, Bin and his colleagues are helping to advance the efficiency and sustainability of modern pharmaceutical R&D.

Science should always be fit for purpose. I have always been driven by a fundamental desire to understand how things work. After earning my PhD in Pharmacology & Toxicology in China, I moved to the US to pursue an advanced research fellowship, eventually working as an instructor in internal medicine and endocrinology. When I transitioned to the pharmaceutical industry, I found my true calling in bioanalytical assay development (the process of designing, optimizing and validating laboratory tests - assays - that accurately measure drugs, biomarkers or other biological molecules in test complex test samples like blood, plasma, serum or tissue). Today at Teva, my role is to develop precise, robust methods to quantify Teva’s drugs in both preclinical animal models and global clinical trials. In our field, we constantly use the phrase "fit for purpose". We are custom-building the exact scientific keys needed to unlock critical data, tracking how fast a drug is absorbed and eliminated so we can determine the perfect dosage for patients.

Teva is pushing the boundaries of innovative medicine. Before joining the company nearly two years ago, I knew Teva primarily as a global leader in generic medicines—a view many people around the world still hold. But the reality inside our walls is entirely different. Teva has a profound, accelerating commitment to the development of innovative medicines, which perfectly aligns with the company’s Pivot to Growth strategy. As a scientist, nothing motivates me more than working for an organization that is actively pushing the boundaries of medicine to benefit patients and society. We aren't just maintaining the status quo; we are investing heavily in our innovative medicine pipeline, and being part of that evolution is incredibly exciting.

Innovation delivers better science and automation makes innovation scalable. Last year, Teva's global R&D Step Up Innovation programme invited employees to vote for the most impactful scientific ideas, with microsampling selected as the winning project. By requiring only tiny sample volumes, microsampling improves efficiency, supports evolving regulatory expectations and contributes to the principles of reducing, refining and replacing animal use in research. As an assay scientist, my role has been to help implement the technology behind microsampling by introducing advanced robotics and transitioning from traditional to high-efficiency platforms. This approach requires far smaller sample volumes and processes up to four times as many samples simultaneously while using fewer laboratory chemicals, enabling faster, more efficient and more sustainable research.

Proactive collaboration ensures right-first-time data. I work in Specialty Bioanalytics, and the collaborative environment here genuinely cheers me up every single day. Within our department, we have distinct groups handling pharmacokinetics, immunogenicity, critical reagents, compliance, and laboratory operations. We don’t operate in isolated silos; we cross-functionally collaborate every step of the way to ensure we deliver high-quality assay data on time to support Teva's preclinical and clinical pipelines. Even though I am still in the middle of my learning curve at Teva, I never hesitate to ask questions.

To succeed in this industry, you must never stop learning. Science evolves rapidly, and you have to keep your curiosity alive. Teva provides an incredible ecosystem for continuous professional growth, offering a massive array of online and in-person technical training programs, as well as a structured corporate Mentoring Program where you are paired with high-level managers to map out your career development. I also took advantage of the Teva Twist project—a unique cross-training program where I partnered with colleagues based in India who trained me directly on post-market regulatory submissions. Looking ahead, I expect myself to keep expanding my skills so I can take on even more responsibility across the organization, using my background in pharmacology and toxicology to make the biggest contribution possible. This continuous learning mindset makes us highly adaptable. When business requirements shift our project priorities or organizational structures, we don't fear change. We understand why the change is happening, pivot smoothly, and ensure we are always pulling together toward the exact same goal. 

NPS-ALL-NP-01868 October 2026